🇺🇸 FDA
Patent

US 11839642

Anti-angiogenin peptides, compositions, and methods of use

granted A61KA61K35/76A61K38/10

Quick answer

US patent 11839642 (Anti-angiogenin peptides, compositions, and methods of use) held by The Board of Regents of the University of Oklahoma expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/76, A61K38/10, A61K47/6901, A61P